The Oral Eosinophil-lowering Drug Dexpramipexole Improves FEV1 Largely Thorough its Effect on FVC-MedSci.cn

The Oral Eosinophil-lowering Drug Dexpramipexole Improves FEV1 Largely Thorough its Effect on FVC

Prussin, C; Bozik, M; Mather, J; Archibald, D; Dworetzky, S; Killingsworth, R; Ochkur, S; Jacobsen, E; Siddiqui, S; Busse, W